Drug Profile
Colesevelam - Ironwood Pharmaceuticals
Alternative Names: CholestaGel; Colesevelam-hydrochloride; GT-31104; GT-31104HB; IW-3718; WelcholLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Ironwood Pharmaceuticals
- Class Amines; Antihyperglycaemics; Antihyperlipidaemics; Digestion aids; Polymers
- Mechanism of Action Bile acid binding protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastro-oesophageal reflux
Most Recent Events
- 12 Nov 2020 Ironwood Pharmaceuticals terminates a phase III trial in Gastro-oesophageal reflux in USA and Canada (PO) (NCT03561090)
- 06 Nov 2020 Ironwood Therapeutics completes a phase-III clinical trials in Gastro-oesophageal reflux in USA (PO) (NCT03561883)
- 05 Nov 2020 Discontinued - Phase-III for Gastro-oesophageal reflux in Canada (PO)